vs
Esperion Therapeutics, Inc.（ESPR）与Limbach Holdings, Inc.（LMB）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Limbach Holdings, Inc.的1.2倍（$168.4M vs $138.9M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 4.3%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 6.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
林巴赫航空发动机是一家由中资控股、总部位于德国的企业，主营航空发动机的研发与制造业务，在航空动力装备领域拥有成熟的生产技术与行业经验。
ESPR vs LMB — 直观对比
营收规模更大
ESPR
是对方的1.2倍
$138.9M
营收增速更快
ESPR
高出139.4%
4.3%
两年增速更快
ESPR
近两年复合增速
6.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $138.9M |
| 净利润 | — | $4.4M |
| 毛利率 | — | 22.4% |
| 营业利润率 | 50.6% | 0.8% |
| 净利率 | — | 3.2% |
| 营收同比 | 143.7% | 4.3% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRLMB
| Q1 26 | — | $138.9M | ||
| Q4 25 | $168.4M | $186.9M | ||
| Q3 25 | $87.3M | $184.6M | ||
| Q2 25 | $82.4M | $142.2M | ||
| Q1 25 | $65.0M | $133.1M | ||
| Q4 24 | $69.1M | $143.7M | ||
| Q3 24 | $51.6M | $133.9M | ||
| Q2 24 | $73.8M | $122.2M |
净利润ESPRLMB
| Q1 26 | — | $4.4M | ||
| Q4 25 | — | $12.3M | ||
| Q3 25 | $-31.3M | $8.8M | ||
| Q2 25 | $-12.7M | $7.8M | ||
| Q1 25 | $-40.5M | $10.2M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $-29.5M | $7.5M | ||
| Q2 24 | $-61.9M | $6.0M |
毛利率ESPRLMB
| Q1 26 | — | 22.4% | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 28.0% | ||
| Q1 25 | — | 27.6% | ||
| Q4 24 | — | 30.3% | ||
| Q3 24 | — | 27.0% | ||
| Q2 24 | — | 27.4% |
营业利润率ESPRLMB
| Q1 26 | — | 0.8% | ||
| Q4 25 | 50.6% | 9.4% | ||
| Q3 25 | -11.4% | 7.2% | ||
| Q2 25 | 8.6% | 7.5% | ||
| Q1 25 | -34.0% | 5.9% | ||
| Q4 24 | -6.4% | 9.1% | ||
| Q3 24 | -31.0% | 8.1% | ||
| Q2 24 | 3.5% | 6.7% |
净利率ESPRLMB
| Q1 26 | — | 3.2% | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | -35.9% | 4.8% | ||
| Q2 25 | -15.4% | 5.5% | ||
| Q1 25 | -62.2% | 7.7% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | -57.2% | 5.6% | ||
| Q2 24 | -83.9% | 4.9% |
每股收益（稀释后）ESPRLMB
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.32 | $1.01 | ||
| Q3 25 | $-0.16 | $0.73 | ||
| Q2 25 | $-0.06 | $0.64 | ||
| Q1 25 | $-0.21 | $0.85 | ||
| Q4 24 | $-0.14 | $0.81 | ||
| Q3 24 | $-0.15 | $0.62 | ||
| Q2 24 | $-0.33 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $15.8M |
| 总债务越低越好 | — | $56.6M |
| 股东权益账面价值 | $-302.0M | $196.3M |
| 总资产 | $465.9M | $377.0M |
| 负债/权益比越低杠杆越低 | — | 0.29× |
8季度趋势，按日历期对齐
现金及短期投资ESPRLMB
| Q1 26 | — | $15.8M | ||
| Q4 25 | $167.9M | $11.3M | ||
| Q3 25 | $92.4M | $9.8M | ||
| Q2 25 | $86.1M | $38.9M | ||
| Q1 25 | $114.6M | $38.1M | ||
| Q4 24 | $144.8M | $44.9M | ||
| Q3 24 | $144.7M | $51.2M | ||
| Q2 24 | $189.3M | $59.5M |
总债务ESPRLMB
| Q1 26 | — | $56.6M | ||
| Q4 25 | — | $30.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M |
股东权益ESPRLMB
| Q1 26 | — | $196.3M | ||
| Q4 25 | $-302.0M | $195.7M | ||
| Q3 25 | $-451.4M | $181.6M | ||
| Q2 25 | $-433.5M | $170.5M | ||
| Q1 25 | $-426.2M | $161.1M | ||
| Q4 24 | $-388.7M | $153.5M | ||
| Q3 24 | $-370.2M | $142.2M | ||
| Q2 24 | $-344.2M | $133.0M |
总资产ESPRLMB
| Q1 26 | — | $377.0M | ||
| Q4 25 | $465.9M | $381.1M | ||
| Q3 25 | $364.0M | $409.1M | ||
| Q2 25 | $347.1M | $343.0M | ||
| Q1 25 | $324.0M | $336.4M | ||
| Q4 24 | $343.8M | $352.1M | ||
| Q3 24 | $314.1M | $324.4M | ||
| Q2 24 | $352.3M | $303.9M |
负债/权益比ESPRLMB
| Q1 26 | — | 0.29× | ||
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRLMB
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $28.1M | ||
| Q3 25 | $-4.3M | $13.3M | ||
| Q2 25 | $-31.4M | $2.0M | ||
| Q1 25 | $-22.6M | $2.2M | ||
| Q4 24 | $-35.0M | $19.3M | ||
| Q3 24 | $-35.3M | $4.9M | ||
| Q2 24 | $-7.2M | $16.5M |
自由现金流ESPRLMB
| Q1 26 | — | — | ||
| Q4 25 | — | $27.9M | ||
| Q3 25 | — | $12.8M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $11.0K | ||
| Q4 24 | — | $18.0M | ||
| Q3 24 | $-35.5M | $4.6M | ||
| Q2 24 | $-7.3M | $13.2M |
自由现金流率ESPRLMB
| Q1 26 | — | — | ||
| Q4 25 | — | 14.9% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | -68.7% | 3.4% | ||
| Q2 24 | -9.9% | 10.8% |
资本支出强度ESPRLMB
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 1.7% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.1% | 2.7% |
现金转化率ESPRLMB
| Q1 26 | — | — | ||
| Q4 25 | — | 2.29× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 2.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LMB
| ODR | $99.8M | 72% |
| GCR | $39.0M | 28% |
